Business News
Search Results 1 - 10 of 899 recordsVectura and GlaxoSmithKline sign licensing agreement
(2 Sep 2010)GlaxoSmithKline (GSK) have signed a worldwide non-exclusive agreement to license some of Vectura's dry powder drug formulation patents in relation to two late stage development compounds in GSK's respiratory ....
Low interest in antibacterials
(1 Sep 2010)Hedwig Kresse, lead infectious disease analyst at Datamonitor, believes that Big Pharma's low interest in antibacterials means that the only defence is improved hygiene in hospitals and stringent measures ....
Treating hearing loss and balance disorders
(30 Aug 2010)GenVec announces a new agreement for the supply of services relating to development materials with Novartis, related to the companies' collaboration in hearing loss and balance disorders. Under this new ....
Depomed licenses Glumetza data and Acuform technology
(30 Aug 2010)Janssen Pharmaceutica has licensed worldwide rights to Depomed 's Acuform gastric retentive drug delivery technology to be used for the non-exclusive development of a fixed dose combination formulation ....
Seattle expands ADC collaboration with Genentech
(26 Aug 2010)Seattle Genetics announces that it has expanded its antibody-drug conjugate (ADC) collaboration agreement with Genentech. Under the expanded agreement, Genentech will pay an upfront fee of US$12 million ....
PerkinElmer acquires VisEn Medical
(25 Aug 2010)PerkinElmer announces that it has acquired VisEn Medical. The acquisition enables PerkinElmer to enhance its cellular imaging business, by expanding the company's technologies and capabilities downstream ....
Research aims to improve diagnosis and therapy of brain diseases
(19 Aug 2010)The partners in a new publicly-funded European research project announce details of the multinational/multidisciplinary program: �CSI: Central Nervous System Imaging.' This three-year ENIAC (European ....
FivePrime in alliance with GSK
(17 Aug 2010)FivePrime Therapeutics announces that it has formed a focused strategic drug discovery alliance with GlaxoSmithKline (GSK). This collaboration gives GSK exclusive access to Five Prime's drug discovery ....
Actient to license and acquire products from UCB
(11 Aug 2010)Actient announces it has completed a transaction to license and acquire six pharmaceutical products from UCB. The product set will form the basis of a commercial platform upon which Actient will continue ....
Approval given to market Abraxane in NZ
(10 Aug 2010)Abraxis BioScience and Specialised Therapeutics announce that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing Abraxane (nanoparticle albumin-bound paclitaxel) ....
